Extension Study Assessing Long Term Safety and Efficacy of IONIS-TTR Rx in Familial Amyloid Polyneuropathy (FAP)

Clinical trial NCT02175004 · COMPLETED

Trial details

NCT number: NCT02175004
Sponsor: Ionis Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

FAP Familial Amyloid Polyneuropathy TTR Transthyretin Amyloidosis

Start date: 2014-06-26
Primary completion: 2020-09-11
Enrollment: 135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.